Prasugrel Hydrochloride is the hydrochloride salt form of prasugrel, an orally bioavailable thienopyridine, with antiplatelet activity. Upon oral administration, the active metabolite of prasugrel targets and irreversibly binds to the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor. It is grouped under the following drug class(es): Antiplatelets. Its therapeutic use is listed as cardiovascular and hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Prasugren hydrochloride, Prasu doc, Prasugren HCl, HCl, Prasugrel Hydrochloride and Prasugrel. Its PubChem CID is 10158453.
Prasugrel hydrochloride
| CAS No | 389574-19-0 |
|---|---|
| Molecular Formula | C20H21ClFNO3S |
| Molecular Weight | 409.9 g/mol |
| Synonyms | [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Prasugrel Hydrochloride is the hydrochloride salt form of prasugrel, an orally bioavailable thienopyridine, with antiplatelet activity.
The listed CAS number is 389574-19-0.
The listed molecular formula is C20H21ClFNO3S.
The listed molecular weight is 409.9 g/mol.
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride.
The source lists Prasugren hydrochloride, Prasu doc, Prasugren HCl, HCl, Prasugrel Hydrochloride and Prasugrel.